Autoimmune diabetes results from inflammatory destruction of the pancreatic beta cells. The final stage hyperglycemia represents the ability of autoreactive T lymphocytes to overcome natural counter- regulatory forces that maintain tissue homeostasis. In this proposal we will study two interesting and potentially important counter-regulatory forces. The first mechanism under investigation is the potential of the infiltrated pancreas to proliferate and regenerate. This process can occur in several animal models and we present evidence that islet cell regeneration can be induced by factors elicited from activated T cells. In this proposal, we plan to determine the extent of duct cell proliferation and islet regeneration following infiltration of islet reactive T cells. We will test the hypothesis that T cells have the ability stimulate the proliferation of ductal cells and their differentiation into islet cells. This will be approached using a transgenic model where the islet antigen is defined and specific subcategories of effector cells can be studied for their ability to induce pancreatic proliferation in vivo. The second counter-regulatory mechanism we propose to study is the ability of localized cytokines to induce immune deviation and prevent inflammation and islet destruction. We present compelling preliminary data to support the notion that this can occur in the NOD mouse. To study this process in a more defined system we will use the targeted transgenic models where the expression of regulatory cytokines in islets can affect the destruction induced by antigen specific CD4 and CD8 T cells. These experiments will allow us to understand the mechanism of this observed immune deviation in vivo and the conditions that T cells can be influenced. These latter experiments will utilize the talents of all of the investigators in this program, and should allow an understanding of the localized regulation of inflammatory cells within islets in vivo. The results from these studies could point to new opportunities for therapeutic intervention.

Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Camacho, S A; Heath, W R; Carbone, F R et al. (2001) A key role for ICAM-1 in generating effector cells mediating inflammatory responses. Nat Immunol 2:523-9
Ragazzo, J L; Ozaki, M E; Karlsson, L et al. (2001) Costimulation via lymphocyte function-associated antigen 1 in the absence of CD28 ligation promotes anergy of naive CD4+ T cells. Proc Natl Acad Sci U S A 98:241-6
Ozaki, M E; Webb, S R (2000) Controlling mature CD4+ T cell responses. Immunol Res 21:345-55
Nugent, C T; Morgan, D J; Biggs, J A et al. (2000) Characterization of CD8+ T lymphocytes that persist after peripheral tolerance to a self antigen expressed in the pancreas. J Immunol 164:191-200
Gallichan, W S; Balasa, B; Davies, J D et al. (1999) Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. J Immunol 163:1696-703
Kreuwel, H T; Morgan, D J; Krahl, T et al. (1999) Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus. J Immunol 163:4335-41
Morgan, D J; Kreuwel, H T; Sherman, L A (1999) Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens. J Immunol 163:723-7
Morgan, D J; Kurts, C; Kreuwel, H T et al. (1999) Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci U S A 96:3854-8
Ozaki, M E; Coren, B A; Huynh, T N et al. (1999) CD4+ T cell responses to CD40-deficient APCs: defects in proliferation and negative selection apply only with B cells as APCs. J Immunol 163:5250-6
Gallichan, W S; Kafri, T; Krahl, T et al. (1998) Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum Gene Ther 9:2717-26

Showing the most recent 10 out of 11 publications